Basit öğe kaydını göster

dc.contributor.authorAkbaş, İlker
dc.contributor.authorÇakır, Zeynep
dc.contributor.authorKocak, Abdullah Osman
dc.contributor.authorÜnlü, Alpaslan
dc.contributor.authorCan, Nazım Onur
dc.contributor.authorVural, Mert
dc.contributor.authorKöse, Muhammed Zübeyr
dc.date.accessioned2022-12-07T12:26:55Z
dc.date.available2022-12-07T12:26:55Z
dc.date.issued2021en_US
dc.identifier.citationAkbal, I., Cakir, Z., Kocak, A.O., Unlu, A., Can, N.O., Vural, M. & Köse, M.Z. (2021). Clinical utility of EDACS-ADP in patients admitted with chest pain to an emergency department. Disaster and Emergency Medicine Journal, 6(1), 33-40. http://doi.org/10.5603/DEMJ.a2021.0008en_US
dc.identifier.issn2451-4691
dc.identifier.urihttp://doi.org/10.5603/DEMJ.a2021.0008
dc.identifier.urihttps://hdl.handle.net/11436/7238
dc.description.abstractIntroduction: Acute coronary syndrome (ACS) is a common cause of mortality and morbidity. An ACS diagnosis can be made with electrocardiogram (ECG) and cardiac markers. However, despite medical advances, 2-5% of ACS patients are undiagnosed and discharged from emergency departments (EDs) because clinicians often find it difficult not only to diagnose and treat high-risk patients but also to define nonemergency diseases or safely discharge healthy patients. Risk stratification can be prevented, and inappropriate diagnosis and treatment protocols can be identified. The ED Assessment of Chest Pain Score-Accelerated Diagnostic Protocol (EDACS-ADP) scoring system, developed to identify patients with chest pain but at low risk for a major adverse cardiac event (MACE), is the first score based on clinical data from emergency medicine. Aim: This study investigates the usability of EDACS-ADP in Turkey. Material and Methods: This is a prospective observational study of 392 patients. The primary outcome was a major adverse cardiovascular event (MACE) within thirty days. Results: A total of 116 MACEs occurred in 65 (16,6%) patients during a one-month follow-up. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (+ LR), and negative likelihood ratio (-LR) values of the EDACS-ADP score for the evaluation of 30-day MACE rate in patients who admitted with chest pain for two months were as follows: 96.9%, 64.5%, 35.2%, 99.1%, + LR: 2.73, and -LR: 0.05. Conclusions: Most of these patients were classified by the EDACS-ADP as low risk and suitable for discharge. The 30-day MACE rate of development was significantly low (0.9%) and acceptable in patients grouped as low risk.en_US
dc.language.isoengen_US
dc.publisherVia Medicaen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectADPen_US
dc.subjectChest painen_US
dc.subjectChest pain scoreen_US
dc.subjectEDACSen_US
dc.titleClinical utility of EDACS-ADP in patients admitted with chest pain to an emergency departmenten_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorÜnlü, Alpaslan
dc.identifier.doi10.5603/DEMJ.A2021.0008en_US
dc.identifier.volume6en_US
dc.identifier.issue1en_US
dc.identifier.startpage33en_US
dc.identifier.endpage40en_US
dc.relation.journalDisaster and Emergency Medicine Journalen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster